481 related articles for article (PubMed ID: 10578124)
1. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry.
Nilsson T; Longmore J; Shaw D; Olesen IJ; Edvinsson L
Br J Pharmacol; 1999 Nov; 128(6):1133-40. PubMed ID: 10578124
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
[TBL] [Abstract][Full Text] [Related]
3. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
Hamel E; Robert JP; Young AR; MacKenzie ET
J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences.
Jansen I; Olesen J; Edvinsson L
Acta Physiol Scand; 1993 Feb; 147(2):141-50. PubMed ID: 8386424
[TBL] [Abstract][Full Text] [Related]
6. Bovine isolated middle cerebral artery contractions to antimigraine drugs.
Roon KI; Maassen Van Den Brink A; Ferrari MD; Saxena PR
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):591-6. PubMed ID: 10598799
[TBL] [Abstract][Full Text] [Related]
7. 5-hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries.
Morecroft I; MacLean MR
Br J Pharmacol; 1998 Sep; 125(1):69-78. PubMed ID: 9776346
[TBL] [Abstract][Full Text] [Related]
8. Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation.
Razzaque Z; Heald MA; Pickard JD; Maskell L; Beer MS; Hill RG; Longmore J
Br J Clin Pharmacol; 1999 Jan; 47(1):75-82. PubMed ID: 10073743
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
[TBL] [Abstract][Full Text] [Related]
10. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
Bouchelet I; Case B; Olivier A; Hamel E
Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348
[TBL] [Abstract][Full Text] [Related]
11. 5-HT receptors mediating external carotid vasoconstriction in vagosympathectomized dogs.
Villalón CM; Centurión D; Sánchez-López A; De Vries P; Saxena P
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1057-67. PubMed ID: 11216445
[TBL] [Abstract][Full Text] [Related]
12. Mediation by 5-HT1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries.
Deckert V; Pruneau D; Elghozi JL
Br J Pharmacol; 1994 Jul; 112(3):939-45. PubMed ID: 7921624
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic characterization of contractile serotonergic receptors in human isolated mesenteric artery.
Gul H; Yildiz O; Simsek A; Balkan M; Ersoz N; Cetiner S; Isimer A; Sen D
J Cardiovasc Pharmacol; 2003 Feb; 41(2):307-15. PubMed ID: 12548093
[TBL] [Abstract][Full Text] [Related]
14. Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein.
Valentin JP; Bonnafous R; John GW
Br J Pharmacol; 1996 Sep; 119(1):35-42. PubMed ID: 8872354
[TBL] [Abstract][Full Text] [Related]
15. Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.
van den Broek RW; Bhalla P; VanDenBrink AM; de Vries R; Sharma HS; Saxena PR
Cephalalgia; 2002 Mar; 22(2):83-93. PubMed ID: 11972574
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the human basilar artery contractile response to 5-HT and triptans.
Silva SA; Marques FB; Fontes Ribeiro CA
Fundam Clin Pharmacol; 2007 Jun; 21(3):265-72. PubMed ID: 17521295
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats.
MacLean MR; Sweeney G; Baird M; McCulloch KM; Houslay M; Morecroft I
Br J Pharmacol; 1996 Nov; 119(5):917-30. PubMed ID: 8922741
[TBL] [Abstract][Full Text] [Related]
18. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
Schoeffter P; Hoyer D
J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176
[TBL] [Abstract][Full Text] [Related]
20. Involvement of 5-HT1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery.
Geerts IS; Matthys KE; Herman AG; Bult H
Br J Pharmacol; 1999 Jul; 127(6):1327-36. PubMed ID: 10455282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]